CGEM (Cullinan Therapeutics) Earnings growth in current year

Official company branding of cullinanoncology.com (CGEM)

Cullinan Therapeutics (CGEM) is accelerating drug development through AI-driven molecular modeling, although testing remains the responsibility of physicians. The annual earnings per share trend illustrates current dynamics, with the metric currently at 7.80. The project remains independent of macro cycles, as risks are concentrated in R&D. Stability is maintained by utilizing accumulated cash to fund costly clinical trials.

CGEM (Cullinan Therapeutics, Inc.) Earnings growth in current year history from 07/04/2022 to 11/17/2026

Comprehensive metric breakdowns and analytics for Cullinan Therapeutics (CGEM)

Fundamental valuation:CGEM Cullinan Therapeutics Inc
Signature product of Cullinan Corp

Analyzing the distribution of the annual change in earnings per share allows for an assessment of Cullinan Therapeutics (CGEM) as a resilient player in the oncology biotech sector. This metric captures the dynamics of net income per share relative to the previous year, reflecting revenue sensitivity to monetary policy, while the absence of geopolitical risks and sanctions in Western jurisdictions ensures the stability of the company's fundamental indicators.

Direct competitors

GMAB: Net earnings per one share growth for the current year|EXEL (Exelixis Inc.) - Earnings growth in current year|Earnings growth in current year nuvalent.com|Earnings per share growth in current year Kymera (KYMR)|IDYA (IDEAYA Biosciences, Inc.) - Earnings per share increase in current year|Earnings growth in current year ELVN (Enliven Therapeutics Inc)|Net earnings per share change in current year ORIC Pharma|Relay Therapeutics Inc - Earnings growth in current year|Earnings per share growth rate in current year Nurix Therapeutics, Inc.|TYRA (Tyra Biosciences, Inc.) - Net earnings per share growth this year|VSTM: Net earnings per one share growth for the current year|GLUE (monterosatx.com) - Earnings growth in current year|Earnings per share growth rate in current year Immuneering Inc. IMRX|Earnings growth in current year CCCC|Black Diamond Therapeutics - Earnings per share growth this year|Repare Therapeutics Inc. - Net earnings per share growth this year|Earnings per share increase in current year PMVP|KPTI: Net earnings per share growth this year|propanc.com - Net earnings per one share growth for the current year|BGMS: Earnings growth in current year|Aadi Bioscience Inc - Earnings per share increase in current year|ALRN (Aileron Therapeutics Inc) - Earnings growth in current year|Earnings per share growth rate in current year blueprintmedicines.com BPMC|Earnings per share growth in current year GlycoMimetics Inc. (GLYC)|SWTX (SpringWorks) - Earnings per share increase in current year